Bsx nyse.

BSX stock has seen extremely strong gains of 55% from levels of $35 in early January 2021 to around $55 now, vs. an increase of about 15% for the S&P 500 over this roughly 3-year period. BSX is ...Boston Scientific stock (NYSE: BSX) has seen a fall of 3% in a month, compared with -5% returns for the broader S&P500 index. The company reported mixed Q4 results last month, with revenue falling ...Find the latest Boston Scientific Corporation (BSX) stock quote, history, news and other vital information to help you with your stock trading and investing.Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions.

Research Boston Scientific's (NYSE:BSX) stock key valuation metrics while comparing it with its industry peers & market side by side.

Boston Scientific's CEO is Mike Mahoney, appointed in Oct 2011, has a tenure of 12.08 years. total yearly compensation is $16.94M, comprised of 8.2% salary and 91.8% bonuses, including company stock and options. directly owns 0.11% of the company’s shares, worth $90.49M. The average tenure of the management team and the board of directors is ...

28 Apr, 2021, 06:30 ET. MARLBOROUGH, Mass., April 28, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $2.752 billion during the first quarter of 2021. This ...Track Boston Scientific Corp. (BSX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights …MARLBOROUGH, Mass., Sept. 1, 2021 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the close of its acquisition of the global surgical business of Lumenis LTD., a privately-held ...MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to ...Blackstone Minerals Limited (BSX) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for BSX is a ratio that tells you the percentage of Blackstone Minerals Limited's (BSX) share price that it pays out in dividends each year.Web

5. Boston Scientific Corporation (NYSE: BSX) Number of Hedge Fund Holders In Q2 2023: 69. Market Capitalization: $73.9 Billion. Founded in 1979 and headquartered in Massachusetts, Boston ...

Dec 1, 2023

Earnings for Boston Scientific are expected to grow by 10.95% in the coming year, from $2.01 to $2.23 per share. Boston Scientific has not formally confirmed its next …MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to ...26 Apr, 2023, 06:30 ET. MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing ...Boston Scientific (NYSE: BSX) ... BSX stock is trading at 27x forward P/E based on our earnings forecast of $1.92 for 2023, compared to the last three-year average of 24x, implying that BSX stock ...Dec 11, 2022 · MARLBOROUGH, Mass., Dec. 11, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) and Acotec Scientific Holdings Limited ("Acotec" and 6669.HK) announced today that Boston Scientific will make a partial offer to acquire a majority stake, up to a maximum of 65%, of shares of Acotec, a Chinese medical technology company that offers solutions designed for a variety of interventional ...

In the last trading session, 7.23 million Boston Scientific Corp. (NYSE:BSX) shares changed hands as the company’s beta touched 0.77. With the company’s per share price at $55.32 changed hands at $0.86 or 1.58% during last session, the market valuation stood at $81.04B. BSX’s last price was a ...MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation ...Hamilton, Bermuda — 10 February 2023 — The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., today reported its 2022 year-end results, with international debt listings and new listings of. Read more The BSX Rings the Bell for Financial Literacy and Announces New Investor Education Initiative About the company. Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ...MARLBOROUGH, Mass., Aug. 15, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic Material (GEM ™) technology used for embolization of blood vessels in the peripheral vasculature. Embolization is a minimally invasive ...

Boston Scientific Corp. BSX (U.S.: NYSE) search. View All companies ` AT CLOSE 4:00 PM ... decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and ...BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44.

BSX support price is $53.82 and resistance is $55.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BSX stock will trade within this expected range on the day. View a ...Company to add novel technology cleared for use in peripheral vasculature to interventional oncology and embolization portfolio. MARLBOROUGH, Mass., Aug. 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the acquisition of Obsidio, Inc., a privately-held company that has developed the Gel Embolic …BSX Boston Scientific Corp. (NYSE) ... The average one-year price target for BSX / Boston Scientific Corp. is $61.692. The forecasts range from a low of $55.55 to a high of $70.35. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is ...MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period.5. Boston Scientific Corporation (NYSE: BSX) Number of Hedge Fund Holders In Q2 2023: 69. Market Capitalization: $73.9 Billion. Founded in 1979 and headquartered in Massachusetts, Boston ...Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...Apr 26, 2023 · 26 Apr, 2023, 06:30 ET. MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing ... Sep 1, 2021 · Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis.. Marlborough, Massachusetts–based Boston Scientific ... In the last trading session, 7.23 million Boston Scientific Corp. (NYSE:BSX) shares changed hands as the company’s beta touched 0.77. With the company’s per share price at $55.32 changed hands at $0.86 or 1.58% during last session, the market valuation stood at $81.04B. BSX’s last price was a ...

Google Finance provides real-time market quotes, international exchanges, up-to-date financial news, and analytics to help you make more informed trading and investment decisions.

Member Rating. Recs. 0. TMFAdriaCimino ( < 20 ) Submitted: 2/20/2020 3:59:14 AM : Start Price: $42.31 NYSE:BSX Score: -3.47. Boston Scientific's many devices as well as a new duodenoscope, used in ERCP procedures will drive revenue. The duodenscope is significant because it is the first FDA-cleared single use one. Report this Post Reply.

Hamilton, Bermuda — 10 February 2023 — The Bermuda Stock Exchange (BSX), a wholly owned subsidiary of Miami International Holdings, Inc., today reported its 2022 year-end results, with international debt listings and new listings of. Read more The BSX Rings the Bell for Financial Literacy and Announces New Investor Education Initiative The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. On November 17, 2023, the average trading volume of BSX was 8.51M shares. BSX) stock’s latest price update. Boston Scientific Corp. (NYSE: BSX) has seen a rise in its stock price by 1.52 in relation to its previous close of 53.85.Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX 0.0% saw its stock ...BSX (U.S.: NYSE) Overview News Boston Scientific Corp. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) 68.77 ( 12/01/23) EPS (TTM) $0.82 Market Cap $82.24 B...The latest price target for . Boston Scientific (NYSE: BSX) was reported by Canaccord Genuity on Monday, November 27, 2023.The analyst firm set a price target for 64.00 expecting BSX to rise to ...Dec 1, 2023 · According to the issued ratings of 16 analysts in the last year, the consensus rating for Boston Scientific stock is Buy based on the current 1 hold rating, 14 buy ratings and 1 strong buy rating for BSX. The average twelve-month price prediction for Boston Scientific is $60.55 with a high price target of $66.00 and a low price target of $55.00 ... Nov 7, 2023 · What is BSX’s CCI (14)? Get a technical analysis of Boston Scientific (BSX) with the latest MACD of 0.05 and RSI of 59.46. Stay up-to-date on market trends with our expert analysis. Nov 22, 2023 · In the last trading session, 7.23 million Boston Scientific Corp. (NYSE:BSX) shares changed hands as the company’s beta touched 0.77. With the company’s per share price at $55.32 changed hands at $0.86 or 1.58% during last session, the market valuation stood at $81.04B. BSX’s last price was a ... 27 Apr, 2022, 06:30 ET. MARLBOROUGH, Mass., April 27, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.026 billion during the first quarter of 2022, growing ...Russell Investments Group Ltd. reduced its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 23.6% in the 2nd quarter, according to the company in its most recent Form 13F ...In certain circumstances, securities with respect to which the relevant exchange has commenced delisting proceedings may continue to be traded pending appeal of that …Nov 28, 2023 · Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, has recently ventured into chronic pain management.The company’s strategic acquisition of ...

We think that Boston Scientific stock (NYSE: BSX) currently is a better pick compared to its industry peer, Medtronic stock (NYSE: MDT), despite it being the more expensive of the two, trading at ...WebBoston Scientific Corp stock price (BSX) NYSE: BSX. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Boston Scientific Corp stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting.13 hours ago ... Our stock screener has flagged BOSTON SCIENTIFIC CORP (NYSE:BSX) as a potential breakout candidate. This occurs when the stock shows signs ...53.54. 53.54. 3,017,800. *Close price adjusted for splits. **Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data... Discover historical prices for BSX stock on Yahoo Finance. View daily, weekly or monthly format back to when Boston Scientific Corporation stock was issued.Instagram:https://instagram. is prana sustainablewhen will diesel prices go downbest growth fundjepi stock dividend yield Feb 3, 2023 · MARLBOROUGH, Mass., Feb. 3, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single ... During the last session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 7.16 million, with the beta value of the company hitting 0.76. At the end of the trading day, the stock’s price was $50.71, reflecting an intraday gain of 0.50% or $0.25. best direct access brokerquicken loan refi October 28, 2023 at 2:55 PM · 16 min read. Boston Scientific Corporation (NYSE: BSX) Q3 2023 Earnings Call Transcript October 26, 2023. Boston Scientific Corporation beats earnings expectations ... best dividend stocks of all time MARLBOROUGH, Mass., Feb. 2, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational 1 basis and 15.1 percent on an organic 2 basis, all compared to the prior year period. The company …MARLBOROUGH, Mass., June 15, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement with Synergy Innovation Co., Ltd, to purchase its majority stake (approximately 64 percent) of M.I.Tech Co., Ltd, ("M.I.Tech") a publicly traded Korean manufacturer and distributor of medical devices for endoscopic and urologic procedures.